← Back to Clinical Trials
Recruiting NCT07281339

NCT07281339 Effect of Hypnobreastfeeding Education in High-Risk Pregnant Women

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07281339
Status Recruiting
Phase
Sponsor Amasya University
Condition High-risk Pregnancy
Study Type INTERVENTIONAL
Enrollment 68 participants
Start Date 2025-10-15
Primary Completion 2026-05-30

Trial Parameters

Condition High-risk Pregnancy
Sponsor Amasya University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 68
Sex FEMALE
Min Age N/A
Max Age N/A
Start Date 2025-10-15
Completion 2026-05-30
Interventions
Hypnobreastfeeding Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

It is thought that hypnobreastfeeding training given to high-risk pregnant women will reduce anxiety levels, increase lactation, encourage breastfeeding, reduce the perception of insufficient milk, and facilitate adaptation to the postpartum breastfeeding process. According to the results of the power analysis, at least 68 high-risk pregnant women, 34 experimental and 34 control, should be included in the study. Data will be collected with the "Pregnancy Information Form", "Anxiety Assessment Scale", " Infant Feeding Intention Instrument", "Postpartum Information Form", "Perception of Insufficient Milk Questionnaire" and "Breastfeeding Adaptation Scale". In the research, hypnobreastfeeding training will be applied by the researcher to the high-risk pregnant women in the experimental group.

Eligibility Criteria

Inclusion Criteria: * High-risk primiparous pregnant women * Those with 28-34 weeks of pregnancy * Those who volunteered to participate in the study * Those who can read and write Turkish Exclusion Criteria: * Those with communication disabilities * Those with psychiatric and mental illnesses * Those who have an obstacle to breastfeeding * Those who have previously attended a birth preparation class * Those who receive breastfeeding-related training and consultancy * Those who gave birth prematurely * Those with anomalies in their babies

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology